Cognizant (Nasdaq-100: CTSH) is one of the world’s leading professional services companies, transforming clients’ business, operating and technology models for the digital era. Our unique industry-based, consultative approach helps clients envision, build and run more innovative and efficient businesses. Headquartered in the U.S., Cognizant is ranked 185 on the Fortune 500 and is consistently listed among the most admired companies in the world.

Cognizant serves all of the top 30 global pharmaceutical companies, nine of the top 10 biotech companies and 13 of the top 15 medical device companies. With a large team of dedicated professionals, we provide domain-aligned consulting, IT, business process and software-as-a-service solutions globally.

Cognizant offers end-to-end services and solutions that span the entire life sciences value chain, across research and development, manufacturing and supply chain, commercial and digital health. Cognizant's Life Sciences division is committed to helping change patient lives for the better by partnering with clients to build solutions to their healthcare challenges. We help our clients continually accelerate the pace of clinical development through innovation and business process transformation.

We enable a patient-centered approach to research and development. Our offerings encompass discovery, preclinical and research; clinical services; pharmacovigilance and safety; and regulatory and compliance. Through close partnership with our clients, we can help them achieve faster treatment discovery and development; facilitate better clinical trial experiences; improve research and collaboration; and reduce costs.